<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-19078" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Venezuelan Equine Encephalitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Crosby</surname>
            <given-names>Brianna</given-names>
          </name>
          <aff>Southeastern Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Crespo</surname>
            <given-names>Maria E.</given-names>
          </name>
          <aff>Campbell University Southeastern regional medical center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Brianna Crosby declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Maria Crespo declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-19078.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Venezuelan equine encephalitis (VEE) is a mosquito-borne disease endemic in regions of Central and South America that causes sporadic outbreaks of equine and human encephalitis. This activity outlines the pathophysiology, evaluation, and treatment of Venezuelan equine encephalitis and reviews the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of Venezuelan equine encephalitis.</p></list-item><list-item><p>Review the evaluation of a patient with Venezuelan equine encephalitis.</p></list-item><list-item><p>Describe the common complications of Venezuelan equine encephalitis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19078&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19078">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-19078.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Venezuelan Equine Encephalitis Virus (VEEV) is the causative viral pathogen of Venezuelan Equine Encephalitis (VEE).&#x000a0;Outbreaks frequently involve both equines &#x02013; including horses, donkeys, mules, zebras &#x02013; and humans.<xref ref-type="bibr" rid="article-19078.r1">[1]</xref><xref ref-type="bibr" rid="article-19078.r2">[2]</xref>&#x000a0;Outbreaks may range over a large geographic area and may last for several months to years.<xref ref-type="bibr" rid="article-19078.r1">[1]</xref>&#x000a0;Sporadic epidemic outbreaks occur most commonly in Central and South America. VEEV exists as both a natural pathogen and a laboratory-developed biologic weapon.<xref ref-type="bibr" rid="article-19078.r1">[1]</xref> Outbreaks have been reported in several South and Central American countries, including Venezuela, Colombia, Peru, Ecuador, Costa Rica, Nicaragua, Honduras, El Salvador, Guatemala, Panama, Mexico, and the United States.<xref ref-type="bibr" rid="article-19078.r3">[3]</xref>&#x000a0;Previous outbreaks of epizootic strains have affected up to 75,000 people during a single epidemic.</p>
      </sec>
      <sec id="article-19078.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>VEEV is a single-stranded positive-sense RNA alphavirus in the <italic toggle="yes">Togaviridae</italic> family.<xref ref-type="bibr" rid="article-19078.r1">[1]</xref><xref ref-type="bibr" rid="article-19078.r2">[2]</xref>&#x000a0;Alphaviruses are mosquito-borne pathogens; transmission between species and between individual humans occurs via mosquitos. Thus VEEV is also classified as an arbovirus.<xref ref-type="bibr" rid="article-19078.r2">[2]</xref>&#x000a0;Arboviruses replicate in arthropod vectors before transfer to vertebrates.<xref ref-type="bibr" rid="article-19078.r4">[4]</xref>&#x000a0;New World alphaviruses &#x02013; including VEEV, Eastern Equine Encephalitis Virus (EEEV), and Western Equine Encephalitis Virus (WEEV) &#x02013; are found in the Americas and can cause severe encephalomyelitis. Old World alphaviruses &#x02013; including chikungunya virus &#x02013; are found in Europe, Asia, and Africa and typically cause fever and polyarthritis.&#x000a0;VEEV was discovered in 1935 after equine outbreaks in Venezuela, Columbia, and Trinidad.<xref ref-type="bibr" rid="article-19078.r2">[2]</xref>&#x000a0;It was not isolated from humans until 1950 during an outbreak in Colombia.<xref ref-type="bibr" rid="article-19078.r3">[3]</xref></p>
        <p>There are six subtypes (I-VI) and many antigenic variants within each subtype. The epizootic strains IAB and IC are responsible for causing encephalitis in equines and humans. These subtypes of VEE are highly pathogenic and can spread quickly through equine populations.&#x000a0;Horses are the key reservoir species and amplification hosts for epizootic viral strains.<xref ref-type="bibr" rid="article-19078.r5">[5]</xref></p>
        <p>The enzootic strains (ID, IE, subtypes II-VI) are usually avirulent in horses and produce mild or no equine illness. However, these strains may still cause significant disease in humans.&#x000a0;Enzootic strains are typically found circulating in rodents. Spillover from these enzootic transmission cycles between rodents and mosquitos may lead to human epidemics. There appears to be no clinical difference in disease caused by epizootic and enzootic strains of VEEV in humans.<xref ref-type="bibr" rid="article-19078.r3">[3]</xref></p>
      </sec>
      <sec id="article-19078.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Epizootic subtypes IAB and IC can cause significant disease in both humans and equines.<xref ref-type="bibr" rid="article-19078.r1">[1]</xref> VEE can occur in all age groups, and there is usually no sex bias during outbreaks. However, infected children are more likely than adults to develop lasting neurological sequelae and fatal encephalitis. Pregnant women infected with VEEV are at risk for congenital disabilities, spontaneous abortions, preterm deliveries, and stillbirths.<xref ref-type="bibr" rid="article-19078.r1">[1]</xref><xref ref-type="bibr" rid="article-19078.r6">[6]</xref></p>
      </sec>
      <sec id="article-19078.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Several species of mosquitos are capable of transmitting both the enzootic and epizootic strains of VEEV.<xref ref-type="bibr" rid="article-19078.r3">[3]</xref>&#x000a0;<italic toggle="yes">Ochlerotatus taeniorhynchus</italic> appears to be the primary mosquito vector during epizootics, while <italic toggle="yes">Culex </italic>species transmit enzootic strains.<xref ref-type="bibr" rid="article-19078.r7">[7]</xref>&#x000a0;Mosquitos feed on infected rodents or equines, infecting the mosquito midgut. Following initial infection, the virus matures and disseminates to secondary organs, including the salivary glands. Virus accumulates in the salivary glands, and blood-feeding releases virions through the mosquito salivary ducts into the new host. The virus then gains entry to a host cell and replicates in the cellular cytoplasm.<xref ref-type="bibr" rid="article-19078.r2">[2]</xref> Infected equines are viral amplification hosts for epizootic strains, while sylvatic rodents are the primary reservoir hosts for enzootic strains.<xref ref-type="bibr" rid="article-19078.r1">[1]</xref> Infected equines and humans develop high viremia loads that can, in turn, be a source of further mosquito infections.&#x000a0;Infected horses shed the virus in body fluids, and humans can then become infected by direct contact or aerosolized fluids.&#x000a0;</p>
        <p>VEEV can cause a spectrum of disease from mild febrile flu-like illness to severe or fatal encephalitis.<xref ref-type="bibr" rid="article-19078.r4">[4]</xref><xref ref-type="bibr" rid="article-19078.r5">[5]</xref><xref ref-type="bibr" rid="article-19078.r7">[7]</xref>&#x000a0;The incubation period for human VEEV infection is typically 2&#x000a0;to 5 days.<xref ref-type="bibr" rid="article-19078.r1">[1]</xref> Between 4&#x000a0;to 14% of infected individuals will develop neurologic disease.<xref ref-type="bibr" rid="article-19078.r2">[2]</xref><xref ref-type="bibr" rid="article-19078.r7">[7]</xref></p>
      </sec>
      <sec id="article-19078.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Examination of the spleen, GI tract, and lymph nodes of infected equines, rodents, and humans shows a significant depletion of lymphocytes.<xref ref-type="bibr" rid="article-19078.r1">[1]</xref> VEEV replicates in lymphoid tissue and causes an inflammatory cell response and cellular necrosis.<xref ref-type="bibr" rid="article-19078.r8">[8]</xref> Additional pathological findings include interstitial pneumonia and alveolar hemorrhage in the lungs and hepatocellular degeneration in the liver in fatal human cases.<xref ref-type="bibr" rid="article-19078.r7">[7]</xref><xref ref-type="bibr" rid="article-19078.r8">[8]</xref>&#x000a0;As the virus clears, tissues recover.<xref ref-type="bibr" rid="article-19078.r8">[8]</xref></p>
      </sec>
      <sec id="article-19078.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Clinical signs of VEEV infection include leukopenia, tachycardia, and fever.&#x000a0;Patients may develop interstitial pneumonia. The physical exam may reveal conjunctival injection, pharyngeal inflammation, and muscle tenderness. The patient may complain of myalgias most typically in the thighs or lumbar back, occipital or retro-orbital headache, fever, and chills.<xref ref-type="bibr" rid="article-19078.r1">[1]</xref> This flu-like prodrome&#x000a0;may progress to encephalitis in up to 14% of patients. Children are more likely to develop encephalitis and have a higher rate of morbidity and mortality from fulminant disease than do adults.<xref ref-type="bibr" rid="article-19078.r4">[4]</xref> Symptoms of more severe disease include tremors, seizures, behavioral changes, hemiparesis, hemichorea, cranial nerve palsies, ataxia, myoclonus, confusion, somnolence, and coma.<xref ref-type="bibr" rid="article-19078.r1">[1]</xref><xref ref-type="bibr" rid="article-19078.r8">[8]</xref>&#x000a0;Generalized congestion, edema, hemorrhage, and vasculitis in the brain, GI tract, and lungs are seen in lethal cases, which comprise less than 1% of human infections.<xref ref-type="bibr" rid="article-19078.r1">[1]</xref><xref ref-type="bibr" rid="article-19078.r7">[7]</xref>&#x000a0;Signs and symptoms of VEE may overlap with other circulating arbovirus infections.</p>
      </sec>
      <sec id="article-19078.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Many cases of Venezuelan equine encephalitis are diagnosed clinically, and cases are probably frequently misdiagnosed as other more common febrile illnesses.<xref ref-type="bibr" rid="article-19078.r3">[3]</xref> Laboratory confirmatory tests do exist. VEEV may be diagnosed by virus isolation or detection in serum or CSF or by serological analysis.<xref ref-type="bibr" rid="article-19078.r3">[3]</xref><xref ref-type="bibr" rid="article-19078.r7">[7]</xref>&#x000a0;A VEEV-specific blocking ELISA has been used to identify the serotype of VEEV in serum.<xref ref-type="bibr" rid="article-19078.r7">[7]</xref> These diagnostic tests are cost-prohibitive, especially in resource-poor countries.<xref ref-type="bibr" rid="article-19078.r3">[3]</xref></p>
        <p>Laboratory testing may reveal leukopenia, lymphopenia, and elevated transaminases.<xref ref-type="bibr" rid="article-19078.r8">[8]</xref>&#x000a0;A lumbar puncture to obtain CSF for analysis may be necessary. CSF may demonstrate a lymphocytic pleocytosis and elevated protein.</p>
      </sec>
      <sec id="article-19078.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Currently, no specific treatment exists for any of the encephalitic arboviruses, including Venezuelan equine encephalitis.&#x000a0;Treatment is supportive or palliative.<xref ref-type="bibr" rid="article-19078.r7">[7]</xref>&#x000a0;Most infections are self-limiting, though neurological sequelae may persist.<xref ref-type="bibr" rid="article-19078.r1">[1]</xref></p>
        <p>Vaccine development for VEEV is ongoing. Though there is currently no FDA-approved human vaccine, TC-83 is a live-attenuated vaccine strain that has been used in&#x000a0;both humans and equines.<xref ref-type="bibr" rid="article-19078.r7">[7]</xref>&#x000a0;The vaccine is not widely available and is typically reserved for laboratory and military personnel at high risk of exposure.&#x000a0;Up to 40% of individuals may develop flu-like symptoms following vaccination.&#x000a0;Approximately 80% of vaccinated individuals will seroconvert. There is also a risk that the vaccine strain may revert to a wildtype virulent strain and potentially cause outbreaks of disease.<xref ref-type="bibr" rid="article-19078.r2">[2]</xref> Formalin-inactivated TC-83 has also been used in equines and humans who do not seroconvert with the live-attenuated vaccine. However, boosters are necessary to maintain immunity.<xref ref-type="bibr" rid="article-19078.r3">[3]</xref>&#x000a0;Post-infection, immunity to a specific serotype appears to be lifelong; however, cross-immunity between serotypes may be poor.</p>
      </sec>
      <sec id="article-19078.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Several arboviruses circulate in overlapping regions throughout Central and South America. VEE clinically presents like other tropical arboviral diseases and may be indistinguishable without expensive confirmatory testing.<xref ref-type="bibr" rid="article-19078.r3">[3]</xref> The differential diagnosis for VEE is extensive. A thorough travel history should be obtained in patients presenting with febrile illness in endemic regions. The clinician should elicit any exposure to ill equids. Careful history-taking and physical examination may aid in differentiating VEEV from other arbovirus infections, but laboratory diagnosis remains most specific.</p>
        <list list-type="bullet">
          <list-item>
            <p>Bacterial meningitis</p>
          </list-item>
          <list-item>
            <p>Chikungunya</p>
          </list-item>
          <list-item>
            <p>Dengue</p>
          </list-item>
          <list-item>
            <p>Eastern equine encephalitis</p>
          </list-item>
          <list-item>
            <p>HSV encephalitis</p>
          </list-item>
          <list-item>
            <p>Lyme disease</p>
          </list-item>
          <list-item>
            <p>Malaria</p>
          </list-item>
          <list-item>
            <p>Rocky mountain spotted fever</p>
          </list-item>
          <list-item>
            <p>Western equine encephalitis</p>
          </list-item>
          <list-item>
            <p>Yellow fever</p>
          </list-item>
          <list-item>
            <p>Zika</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-19078.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Equine mortality is significant and is estimated to be 19-83% during epizootic outbreaks. Fatality rates are much lower in humans, and less than 1% of cases are lethal. Adults are more likely to develop febrile flu-like illness. Children are at greater risk for developing neurological disease or encephalitis.<xref ref-type="bibr" rid="article-19078.r7">[7]</xref> Symptoms of CNS disease may include ataxia, depression, altered mentation, coma, and seizures.<xref ref-type="bibr" rid="article-19078.r2">[2]</xref>&#x000a0;Children are also more likely to suffer from neurological sequelae following recovery from disease.<xref ref-type="bibr" rid="article-19078.r9">[9]</xref></p>
      </sec>
      <sec id="article-19078.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Neurological sequelae may persist following recovery from initial infection with VEEV. Though there is no specific therapy for VEEV, modern medical technology has improved supportive treatments, and many patients will survive even encephalitic disease.<xref ref-type="bibr" rid="article-19078.r9">[9]</xref> Patients may then develop permanent neurological sequelae. These can include seizures, confusion, intellectual disabilities, and behavioral changes. The spectrum of VEEV-induced sequalae ranges from mild and manageable to life-altering. These post-infectious sequelae can develop irrespective of the severity of the preceding febrile illness.<xref ref-type="bibr" rid="article-19078.r9">[9]</xref></p>
        <p>Pregnant women may be at distinct risk of complications from arbovirus infections. VEEV was classified as the first teratogenic arbovirus.&#x000a0;Pregnant women are at risk for congenital disabilities, miscarriage, preterm delivery, and stillbirth.&#x000a0;Vertical transmission from mother to fetus has been documented. Ten fetal autopsies performed during an outbreak demonstrated VEEV in the brains of aborted fetuses.<xref ref-type="bibr" rid="article-19078.r3">[3]</xref><xref ref-type="bibr" rid="article-19078.r6">[6]</xref>&#x000a0;Infants born to mothers with Venezuelan Equine Encephalitis may have neurological sequelae or fatal cerebral lesions. Worldwide, infectious diseases remain one of the most common causes of maternal mortality, and it is estimated that up to 90% of pregnancies occur in regions where arboviruses are endemic or epidemic.<xref ref-type="bibr" rid="article-19078.r6">[6]</xref></p>
      </sec>
      <sec id="article-19078.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>As there is no specific treatment for Venezuelan equine encephalitis, avoiding infection is the best prevention. Outbreaks may be controlled by reducing mosquito populations, as arthropods serve as the primary vector of infection. Humans, especially those who have frequent contact with equines, should limit physical exposure to mosquitos, wear protective clothing, and use frequent applications of repellants. Aerosolized insecticide applications in endemic areas will also contribute to a reduction in mosquito populations.<xref ref-type="bibr" rid="article-19078.r3">[3]</xref></p>
        <p>Epizootic outbreaks may also be prevented through mass vaccination of horses with the TC-83 live-attenuated vaccine.<xref ref-type="bibr" rid="article-19078.r1">[1]</xref> TC-83 is licensed and available for equines in endemic regions.<xref ref-type="bibr" rid="article-19078.r4">[4]</xref> Sustained vaccine programs between outbreaks may be necessary to develop herd immunity in equines to limit spillover into humans.<xref ref-type="bibr" rid="article-19078.r3">[3]</xref></p>
      </sec>
      <sec id="article-19078.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Global warming may facilitate the emergence of VEEV epidemics. Climate change can lead to longer transmission seasons, changes in rainy seasons, which increase mosquito populations, and increased geographic distributions of tropical mosquito vectors.<xref ref-type="bibr" rid="article-19078.r3">[3]</xref><xref ref-type="bibr" rid="article-19078.r10">[10]</xref></p>
        <p>Enzootic VEEV exists continuously in tropical regions, and there is a risk of emergence of epizootic strains leading to equine and human outbreaks. In endemic regions, surveillance programs for early detection and implementation of mosquito control and equine vaccination will help control outbreaks.</p>
        <p>VEEV was developed as a biological weapon by the United States and the former Soviet Union during the Cold War. It is classified as a biosafety level 3 by the Centers for Disease Control and as a category B priority pathogen by the National Institute of Allergies and Infectious Diseases.<xref ref-type="bibr" rid="article-19078.r2">[2]</xref>&#x000a0;Laboratory accidents have been reported, with infections occurring from small-volume aerosolized samples.</p>
      </sec>
      <sec id="article-19078.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The diagnosis and treatment of Venezuelan equine encephalitis require a multidisciplinary approach. Healthcare providers in endemic areas must maintain a high degree of suspicion for the diagnosis. Patients will require supportive care for any degree of disease they develop, from mild illness to fulminant encephalitis. Following recovery, some patients will suffer from neurological sequelae and will require continued support from healthcare providers and the community. [Level 5]</p>
      </sec>
      <sec id="article-19078.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=19078&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=19078">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/venezuelan-equine-encephalitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=19078">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/19078/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=19078">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-19078.s17">
        <title>References</title>
        <ref id="article-19078.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weaver</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Ferro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barrera</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Boshell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Navarro</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Venezuelan equine encephalitis.</article-title>
            <source>Annu Rev Entomol</source>
            <year>2004</year>
            <volume>49</volume>
            <fpage>141</fpage>
            <page-range>141-74</page-range>
            <pub-id pub-id-type="pmid">14651460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19078.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lundberg</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Carey</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kehn-Hall</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Venezuelan Equine Encephalitis Virus Capsid-The Clever Caper.</article-title>
            <source>Viruses</source>
            <year>2017</year>
            <month>Sep</month>
            <day>29</day>
            <volume>9</volume>
            <issue>10</issue>
            <pub-id pub-id-type="pmid">28961161</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19078.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aguilar</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Estrada-Franco</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Navarro-Lopez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ferro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Haddow</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Weaver</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Endemic Venezuelan equine encephalitis in the Americas: hidden under the dengue umbrella.</article-title>
            <source>Future Virol</source>
            <year>2011</year>
            <volume>6</volume>
            <issue>6</issue>
            <fpage>721</fpage>
            <page-range>721-740</page-range>
            <pub-id pub-id-type="pmid">21765860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19078.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Go</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Balasuriya</surname>
                <given-names>UB</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>CK</given-names>
              </name>
            </person-group>
            <article-title>Zoonotic encephalitides caused by arboviruses: transmission and epidemiology of alphaviruses and flaviviruses.</article-title>
            <source>Clin Exp Vaccine Res</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>58</fpage>
            <page-range>58-77</page-range>
            <pub-id pub-id-type="pmid">24427764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19078.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Manuja</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gulati</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Virmani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tripathi</surname>
                <given-names>BN</given-names>
              </name>
            </person-group>
            <article-title>Zoonotic Viral Diseases of Equines and Their Impact on Human and Animal Health.</article-title>
            <source>Open Virol J</source>
            <year>2018</year>
            <volume>12</volume>
            <fpage>80</fpage>
            <page-range>80-98</page-range>
            <pub-id pub-id-type="pmid">30288197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19078.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Charlier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Beaudoin</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Couderc</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lortholary</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Lecuit</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Arboviruses and pregnancy: maternal, fetal, and neonatal effects.</article-title>
            <source>Lancet Child Adolesc Health</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>1</volume>
            <issue>2</issue>
            <fpage>134</fpage>
            <page-range>134-146</page-range>
            <pub-id pub-id-type="pmid">30169203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19078.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zacks</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Paessler</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Encephalitic alphaviruses.</article-title>
            <source>Vet Microbiol</source>
            <year>2010</year>
            <month>Jan</month>
            <day>27</day>
            <volume>140</volume>
            <issue>3-4</issue>
            <fpage>281</fpage>
            <page-range>281-6</page-range>
            <pub-id pub-id-type="pmid">19775836</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19078.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Knollmann-Ritschel</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development.</article-title>
            <source>Viruses</source>
            <year>2019</year>
            <month>Feb</month>
            <day>18</day>
            <volume>11</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">30781656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19078.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ronca</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Dineley</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Paessler</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Neurological Sequelae Resulting from Encephalitic Alphavirus Infection.</article-title>
            <source>Front Microbiol</source>
            <year>2016</year>
            <volume>7</volume>
            <fpage>959</fpage>
            <pub-id pub-id-type="pmid">27379085</pub-id>
          </element-citation>
        </ref>
        <ref id="article-19078.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weaver</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Reisen</surname>
                <given-names>WK</given-names>
              </name>
            </person-group>
            <article-title>Present and future arboviral threats.</article-title>
            <source>Antiviral Res</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>85</volume>
            <issue>2</issue>
            <fpage>328</fpage>
            <page-range>328-45</page-range>
            <pub-id pub-id-type="pmid">19857523</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
